Antimalarial drug quality: methods to detect suspect drugs

1 February 2010

An article by Kaur et al published in Therapy (2010) 7(1), 49–57 reviews the problem of suspect antimalarials and discusses methods available to help determine their quality.

Malaria is a major public health problem in the endemic countries of Africa, Asia and Latin America. Poor quality antimalarials are of major, but neglected, concern in the control of Plasmodium falciparum malaria. They cause treatment failure and economic loss, and engender drug resistance and loss of confidence in health systems. The emergence of resistance to the artemisinin derivatives in Asia bodes ill for malaria control in Africa, and strenuous efforts are needed to improve the quality of the world’s supply of antimalarials.

You can read the rest of the article by clicking here.